4
Changes in Ownership
INSMED Inc Filed Acc 0001628280-25-021897
Chair and CEO sold 6,830 shares at an average $72.57 ($495,668)
- Chair and CEO acquired 6,830 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Lewis William · Chair and CEO
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-05-01 | Exercise or conversion : show line 1 in the form 10b5-1 | +6,830 | $10.85 | $74,106 | 240,754 | I |
| 2025-05-01 | Sale : show line 2 in the form 10b5-1 | −2,629 | $72.24 | $189,919 | 238,125 | I |
| 2025-05-01 | Sale : show line 3 in the form 10b5-1 | −4,201 | $72.78 | $305,749 | 233,924 | I |
| Open-market sales · 6,830 sh · avg $72.57 · $495,668 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-05-01 | Exercise or conversion : show line 4 in the form 10b5-1 Stock Option (right to buy) | −6,830 | 170,820 | I |
Loading xslF345X05/wk-form4_1746218581.xml…